Takeda Inks Deal With China’s Innovent to Develop Cancer Drugs

Takeda Inks Deal With China’s Innovent to Develop Cancer Drugs



Takeda Inks Deal With China’s Innovent to Develop Cancer Drugs
Takeda Pharmaceutical Co. has struck a deal with China’s Innovent Biologics Inc. to co-develop cancer therapies, underscoring a surge of global pharma giants turning to Chinese biotech companies to create blockbuster drugs.


www.bloomberg.com
#Takeda #Inks #Deal #Chinas #Innovent #Develop #Cancer #Drugs

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *